Zai Lab Limited - ADR
NASDAQ:ZLAB 4:00:00 PM EDT
| Market Cap (Intraday) | 1.51B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $14.83 |
| 50-Day MA | $17.62 |
| 200-Day MA | $23.77 |
Zai Lab Limited - ADR Stock, NASDAQ:ZLAB
Jinchuang Plaza, Building 1, 4/F, Shanghai, Shanghai 201210
China
Phone: +86.21.6163.2588
Number of Employees: 2175
Description
Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.